AB28770

Anti-PCSK9 抗体

Name: Anti-PCSK9 抗体 (ab28770) | Abcam
Brand: Abcam Limited
SKU: AB28770
Price: 84000 JPY
Availability: InStock
Rating: 4 (2 reviews)

Anti-PCSK9 antibody

(2 Reviews)

(17 Publications)

Goat Polyclonal PCSK9 antibody. Suitable for WB and reacts with Human samples. Cited in 17 publications. Immunogen corresponding to Synthetic Peptide within Human PCSK9 aa 650 to C-terminus.

別名を表示する

NARC1, PSEC0052, PCSK9, Proprotein convertase subtilisin/kexin type 9, Neural apoptosis-regulated convertase 1, Proprotein convertase 9, Subtilisin/kexin-like protease PC9, NARC-1, PC9

1 Images

Unknown

Western blot - Anti-PCSK9 antibody (AB28770)

All lanes:

Western blot - Anti-PCSK9 antibody (ab28770) at 0.3 µg/mL

All lanes:

Human Adipose lysate in RIPA buffer at 35 µg

Predicted band size: 74 kDa

true

Key facts

宿主種

Goat

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

交差種

Human

アプリケーション

applications

免疫原

Synthetic Peptide within Human PCSK9 aa 650 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q8NBP7

style

left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.3-1 µg/mL", "WB-species-notes": "<p>1 hour primary incubation is recommended for this product.</p>" } } }

style

left-column

style

left-column

出荷温度及び保存条件

製品の状態

Liquid

精製方法

Affinity purification Immunogen

精製に関する特記事項

ab28770 was purified from goat serum by ammonium sulphate precipitation prior to immunogen affinity chromatography.

バッファー組成

pH: 7.3 Preservative: 0.02% Sodium azide Constituents: Tris buffered saline, 0.5% BSA

出荷温度

Blue Ice

短期保存温度

+4°C

長期保存温度

-20°C

分注に関する情報

Upon delivery aliquot

保管に関する情報

Avoid freeze / thaw cycle

style

left-column

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a protein responsible for the regulation of cholesterol levels by binding to low-density lipoprotein receptors (LDLR) on hepatocytes. This interaction marks the LDLRs for degradation reducing the liver's ability to clear LDL cholesterol from the blood. PCSK9 has a molecular weight of approximately 74 kDa. The protein is mainly expressed in the liver but is also found in the intestine and kidneys. PCSK9 is referred to as NARC-1 standing for neural apoptosis-regulated convertase 1 highlighting its role in the liver's cholesterol management system.

Biological function summary

PCSK9 influences cholesterol homeostasis by its important role in degrading LDL receptors. It functions independently rather than as part of larger protein complexes. PCSK9 gains particular interest in therapeutic contexts where its inhibition can lead to increased LDLR levels and enhanced clearance of LDL cholesterol. Biotinylated PCSK9 and mouse PCSK9 variants provide significant tools for experimental study. Kits such as the PCSK9 ELISA kit enable detailed measurement of PCSK9 levels in blood samples providing insights into cholesterol metabolism dynamics.

Pathways

PCSK9 operates within the lipid metabolism pathway and the cholesterol biosynthesis pathway. The protein's activity affects the fate of LDL cholesterol within these pathways. It interacts with proteins such as apolipoprotein B (ApoB) which plays a central role in the structural component of LDL particles. The modulation of these pathways by PCSK9 highlights the significance of its function in maintaining cardiovascular health and managing cholesterol levels.

PCSK9 is closely linked to hypercholesterolemia and coronary artery disease. Mutations in PCSK9 can lead to autosomal dominant hypercholesterolemia due to its effect on LDL receptor degradation. Other proteins such as ApoB and LDLR are involved in these conditions tightly interacting with PCSK9's regulatory function. A better understanding of PCSK9's role offers potential therapeutic targets for cardiovascular disease interventions especially through the development of PCSK9 antibodies and PCSK9 assays that adjust cholesterol levels.

style

left-column

style

left-column

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

Visit the General protocols
Visit the Troubleshooting

style

left-column

ターゲットの情報

Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members : low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments (PubMed : 18039658). Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation (PubMed : 17461796, PubMed : 18197702, PubMed : 18799458, PubMed : 22074827). Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway (PubMed : 18660751). Inhibits epithelial Na(+) channel (ENaC)-mediated Na(+) absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways.

See full target information PCSK9

style

left-column

文献 (17)

Recent publications for all applications. Explore the full list and refine your search

Cancers 17: PubMed40563628

2025

Inhibition of PCSK9 Attenuates Liver Endothelial Cell Activation Induced by Colorectal Cancer Stem Cells During Liver Metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Ander Martin,Daniela Gerovska,Marcos J Arauzo-Bravo,Maitane Duarte García-Escudero,Helena García García,Iratxe Bañares,Naroa Fontal,Geraldine Siegfried,Serge Evrad,Simon Pernot,Abdel-Majid Khatib,Iker Badiola

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2408514 PubMed40192514

2025

PCSK9 Promotes the Malignancy of Triple-negative Breast Cancer Cells by Reducing Cholesterol Levels at the Plasma Membrane to Activate EGFR and HER3.

Applications

Unspecified application

Species

Unspecified reactive species

Tianhong Li,Renfei Wu,Kathy Qian Luo

Theranostics 13:531-542 PubMed36632236

2023

SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Nunzia D'Onofrio,Francesco Prattichizzo,Raffaele Marfella,Celestino Sardu,Elisa Martino,Lucia Scisciola,Lorenza Marfella,Rosalba La Grotta,Chiara Frigé,Giuseppe Paolisso,Antonio Ceriello,Maria Luisa Balestrieri

Journal of experimental & clinical cancer research : CR 41:303 PubMed36242053

2022

PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Lu Wang,Shuangshuang Li,Huanhua Luo,Qi Lu,Shuwen Yu

Foods (Basel, Switzerland) 10: PubMed34829135

2021

The Effects of Anthocyanin-Rich Bilberry Extract on Transintestinal Cholesterol Excretion.

Applications

Unspecified application

Species

Unspecified reactive species

Jimin Hong,Minji Kim,Bohkyung Kim

Atherosclerosis 326:47-55 PubMed33933263

2021

Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function.

Applications

Unspecified application

Species

Unspecified reactive species

Stéphane Ramin-Mangata,Aurélie Thedrez,Brice Nativel,Nicolas Diotel,Valentin Blanchard,Matthieu Wargny,Audrey Aguesse,Stéphanie Billon-Crossouard,Cécile Vindis,Cédric Le May,Philippe Hulin,Mathieu Armanet,Valery Gmyr,François Pattou,Mikaël Croyal,Olivier Meilhac,Estelle Nobécourt,Bertrand Cariou,Gilles Lambert

Frontiers in oncology 10:609663 PubMed33489919

2021

Proprotein Convertase Subtilisin/Kexin Type 9 Promotes Gastric Cancer Metastasis and Suppresses Apoptosis by Facilitating MAPK Signaling Pathway Through HSP70 Up-Regulation.

Applications

Unspecified application

Species

Unspecified reactive species

Beili Xu,Shuyu Li,Yong Fang,Yanting Zou,Dongqiang Song,Shuncai Zhang,Yu Cai

JCI insight 5: PubMed33119548

2020

microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production.

Applications

Unspecified application

Species

Unspecified reactive species

Jianjie Dong,Ming He,Jie Li,Ariane Pessentheiner,Chen Wang,Jin Zhang,Yameng Sun,Wei-Ting Wang,Yuqing Zhang,Junhui Liu,Shen-Chih Wang,Po-Hsun Huang,Philip Lsm Gordts,Zu-Yi Yuan,Sotirios Tsimikas,John Yj Shyy

PloS one 14:e0220254 PubMed31437157

2019

Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer's disease: A genetic and proteomic multi-cohort study.

Applications

Unspecified application

Species

Unspecified reactive species

Cynthia Picard,Alexandre Poirier,Stéphanie Bélanger,Anne Labonté,Daniel Auld,Judes Poirier

BMC biology 17:4 PubMed30646909

2019

In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Alba Carreras,Luna Simona Pane,Roberto Nitsch,Katja Madeyski-Bengtson,Michelle Porritt,Pinar Akcakaya,Amir Taheri-Ghahfarokhi,Elke Ericson,Mikael Bjursell,Marta Perez-Alcazar,Frank Seeliger,Magnus Althage,Ralph Knöll,Ryan Hicks,Lorenz M Mayr,Rosie Perkins,Daniel Lindén,Jan Borén,Mohammad Bohlooly-Y,Marcello Maresca

View all publications

style

left-column

style

left-column

style

right-column

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。

保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com

Anti-PCSK9 抗体

Anti-PCSK9 antibody

Western blot - Anti-PCSK9 antibody (AB28770)

Key facts

宿主種

クローン性

アイソタイプ

キャリアフリー

交差種

アプリケーション

免疫原

Reactivity data

出荷温度及び保存条件

製品の状態

精製方法

精製に関する特記事項

バッファー組成

出荷温度

短期保存温度

長期保存温度

分注に関する情報

保管に関する情報

補足情報

Biological function summary

Pathways

製品プロトコール

ターゲットの情報

文献 (17)

代替製品

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

組合せ製品

Primary Antibodies

Secondary Antibodies

Primary Antibodies

Primary Antibodies

Abcam product promise